United States - English - NLM (National Library of Medicine)

ge healthcare, medi-physics, inc. - sodium iodide, i-123 (unii: 29ukx3a616) (sodium iodide, i-123 - unii:29ukx3a616) - capsule - 100 uci - sodium iodide i-123 is indicated for use in the evaluation of thyroid function and/or morphology. none known.

Australia - English - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - sodium iodide(123i), quantity: 100 mbq - capsule - excipient ingredients: dibasic sodium phosphate heptahydrate; sodium bicarbonate; sodium thiosulfate pentahydrate; sodium hydroxide; purified water; sunset yellow fcf; quinoline yellow; titanium dioxide; brilliant blue fcf; carmoisine; gelatin; ethanol; shellac; pharmaceutical glaze; carbon black - sodium iodide [123] diagnostic capsules are for diagnostic imaging of thyroid tissue.

Australia - English - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - sodium iodide(123i), quantity: 1 mbq - capsule - excipient ingredients: dibasic sodium phosphate heptahydrate; sodium bicarbonate; sodium thiosulfate pentahydrate; sodium hydroxide; purified water; sunset yellow fcf; quinoline yellow; titanium dioxide; brilliant blue fcf; carmoisine; gelatin; ethanol; shellac; pharmaceutical glaze; carbon black - sodium iodide [123] diagnostic capsules are for diagnostic imaging of thyroid tissue.

Australia - English - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - sodium iodide(131i), quantity: 50 mbq - oral liquid, solution - excipient ingredients: sodium thiosulfate pentahydrate; water for injections; sodium bicarbonate - sodium iodide (131i) solution bp (for therapy) is indicated in the treatment of hyperthyroidism's and the detection and ablation of residual functioning thyroid tissue in differentiated thyroid carcinoma

United States - English - NLM (National Library of Medicine)

cardinal health 418, inc - sodium iodide i-123 (unii: 29ukx3a616) (iodide ion i-123 - unii:98qpv8670c) - iodide ion i-123 100 uci - administration of sodium iodide i 123 is indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology. to date there are no known contraindications to the use of sodium iodide i 123 capsules.

United States - English - NLM (National Library of Medicine)

curium us llc - sodium iodide i-123 (unii: 29ukx3a616) (iodide ion i-123 - unii:98qpv8670c) - iodide ion i-123 100 uci - administration of sodium iodide i 123 capsules is indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology. to date there are no known contraindications to the use of sodium iodide i 123 capsules.

United States - English - NLM (National Library of Medicine)

international isotopes inc - sodium iodide i-131 (unii: 29vco8achh) (iodide ion i-131 - unii:4gc1foq22u) - iodide ion i-131 3500 mci in 1 ml - sodium iodide i-131 is indicated for the treatment of hyperthyroidism and selected cases of thyroid carcinoma. sodium iodide i-131 is contraindicated in: - patients with vomiting and diarrhea [see warning and precautions (5.7)] . - pregnancy [see warnings and precautions (5.4), see use in specific populations (8.1)] . - lactation [see warnings and precautions (5.5)] . - patients receiving concurrent anti-thyroid therapy [see warning and precautions (5.1) and drug interactions (7)] . risk summary sodium iodide i-131 is contraindicated in pregnancy because fetal exposure can lead to neonatal hypothyroidism, which in some cases is severe and irreversible. data from the published literature describe thyroid abnormalities after fetal exposure; including agene

United States - English - NLM (National Library of Medicine)

jubilant draximage inc., dba jubilant radiopharma - sodium iodide i-131 (unii: 29vco8achh) (iodide ion i-131 - unii:4gc1foq22u) - iodide ion i-131 100 mci - sodium iodide i 131 capsules diagnostic is indicated for use in adults for: - assessment of thyroid function using radioactive iodine (rai) uptake test - imaging the thyroid (scintigraphy) sodium iodide i 131 capsules diagnostic is contraindicated in pregnancy [see warnings and precautions (5.1) , use in specific populations (8.1) ]. risk summary sodium iodide i 131 capsules diagnostic is contraindicated in pregnancy because fetal exposure can lead to neonatal hypothyroidism, which in some cases is severe and irreversible. data from the published literature describe reports of neonatal thyroid abnormalities after fetal exposure, including agenesis of the thyroid and hypothyroidism (see clinical considerations, data ). no animal reproductive studies have been conducted. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnanc

United States - English - NLM (National Library of Medicine)

vettek - sodium iodide (unii: f5wr8n145c) (iodide ion - unii:09g4i6v86q) - iodide ion 20 g in 100 ml - for use as an aid in the treatment of actinomycosis (lumpy jaw) actinobacillosis (wooden tongue) and necrotic stomatitis in cattle. the use of sodium iodide is contraindicated in pregnancy and hyperthyroidism. for animal use only. keep out of reach of children.

Australia - English - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - sodium iodide(131i), quantity: 1201 mbq - oral liquid, solution - excipient ingredients: sodium bicarbonate; sodium thiosulfate pentahydrate; water for injections - .